- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03170999
Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
July 31, 2020 updated by: GlaxoSmithKline
Generation and Cognitive Testing of Informative and Suitable Items for a COPD Exacerbation Recognition Tool (CERT) for Detection of Exacerbations of COPD in Chinese Patients
It has been observed that COPD exacerbations are under-reported in China.
One of the reasons for this is Chinese subjects with COPD cannot describe the symptoms of exacerbation mentioned in English.
Hence this study aims to create a tool called CERT that will help Chinese physicians and subjects with COPD to recognize and report exacerbations.
The study will be carried out in 4 stages: item identification, cognitive briefing, item reduction and creation of final CERTs.
Two CERTs will be prepared, one for subjects with COPD and another for physicians.
A total of approximately 200 subjects will be included in the study and each subject will contribute to only one step.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
199
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Chongqing, China, 400010
- GSK Investigational Site
-
Shenyang, China
- GSK Investigational Site
-
-
Zhejiang
-
Hangzhou, Zhejiang, China
- GSK Investigational Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects having COPD attending the outpatient respiratory specialist clinics of tier 3 hospitals for their disease will be included in the study.
Description
Inclusion Criteria:
- Male or female of age greater than or equal to 40 years.
- Spirometrically confirmed COPD according to diagnostic criteria in Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2016.
- A treated exacerbation of COPD within 3 months prior to the study visit.
- Willing and able to provide informed consent, and able to participate in focus groups or cognitive interviews.
- Literacy is not a requirement for any of the groups.
Exclusion Criteria:
- Current diagnosis of asthma or clinically relevant bronchiectasis. Note: Subjects with Asthma COPD Overlap Syndrome (ACOS) are eligible.
- Subjects with a concurrent significant, uncontrolled, active medical condition or disease state of other organ diseases or systematic diseases; psychiatric condition; cognitive impairment or any other reasons that in the investigator's opinion, would place subjects at risk or interfere with study evaluation or affect participation in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Subjects included in Focus groups
Approximately 45 subjects with COPD will participate in the focus group interviews for item identification.
The group may contain subjects who are functionally illiterate and at least one third women will be recruited.
|
Focus group interviews will take place to discuss the key domains of COPD exacerbation which then will be used in the formation of the draft item set.
|
Subjects included in cognitive interviews
Approximately 9 subjects with COPD will be involved in cognitive interviews and will be asked to respond to all of the items in the draft item set.
|
Items that form the draft item set will be subject to cognitive debriefing.
Questions in the draft item set will collect information on whether the subjects with COPD have experienced that item during an exacerbation.
Changes in this draft set will result in the formation of candidate item set.
|
Subjects included in candidate item set
Approximately 150 subjects with COPD will respond to the questions in candidate item set.
|
Item reduction will be done using candidate item set and the subjects will be asked to respond to the candidate items on a 4-point scale in terms of how that item changed with the onset of the last episode.
Item reduction will take into account frequency and magnitude of items, floor and ceiling items and consistency between regions.
The candidate item set will then be used for generation of CERT.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
COPD symptom item set to identify common phrases of COPD exacerbation
Time Frame: Day 1
|
The most frequently used items to describe the symptomatic characteristics of the onset of an exacerbation will be identified from COPD symptom item set.
|
Day 1
|
Preparation of COPD Exacerbation Recognition tool (CERT)
Time Frame: Day 1
|
Two simple educational hand-outs called CERT will be prepared, one for the subjects with COPD and the other for the physicians which will help Chinese physicians and subjects in recognizing and reporting COPD exacerbations.
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 29, 2018
Primary Completion (ACTUAL)
May 29, 2020
Study Completion (ACTUAL)
May 29, 2020
Study Registration Dates
First Submitted
May 2, 2017
First Submitted That Met QC Criteria
May 26, 2017
First Posted (ACTUAL)
May 31, 2017
Study Record Updates
Last Update Posted (ACTUAL)
August 3, 2020
Last Update Submitted That Met QC Criteria
July 31, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201098
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Airway Obstruction
-
Beth Israel Deaconess Medical CenterMedWaves, IncRecruitingAirway Obstruction | Central Airway ObstructionUnited States
-
McMurray Medical Group, LLCCompletedUpper Airway ObstructionUnited States
-
Massachusetts General HospitalCompletedUpper Airway ObstructionUnited States
-
Rigshospitalet, DenmarkCompletedUpper Airway ObstructionDenmark
-
Zhongda HospitalUnknownMalignant Airway ObstructionChina
-
Assistance Publique - Hôpitaux de ParisRecruitingRespiratory Distress | Upper Airway ObstructionFrance
-
ResMedCompletedRespiratory Failure | Respiratory Insufficiency | Upper Airway ObstructionUnited States
-
Massachusetts General HospitalCompletedMechanical Ventilation Complication | Upper Airway ObstructionUnited States
-
Aerin MedicalOhio State UniversityCompletedNasal ObstructionUnited States
-
Airiver Medical, Inc.Libra MedicalRecruitingCentral Airway ObstructionGeorgia
Clinical Trials on Focus group interview
-
M.D. Anderson Cancer CenterRecruiting
-
University Hospital, ToulouseFondation pour la Recherche MédicaleCompleted
-
Universitair Ziekenhuis BrusselUnknownPatient Satisfaction | Patient PreferenceBelgium
-
Klinik BarmelweidCompletedCoronary Disease | Cardiac Rehabilitation | Physical Therapy | Physical Exertion | Exercise TestSwitzerland
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University of SienaNot yet recruitingStress, Psychological | Injuries | Injury;Sports | Dancing
-
University of Alabama at BirminghamWithdrawnStroke | Caregiver Burden | Patient Satisfaction | Disability Physical
-
Herlev HospitalCompletedStroke, IschemicDenmark
-
Hadassah Medical OrganizationRecruitingPre-Eclampsia | Gestational DiabetesIsrael
-
Verity HaffendenNot yet recruitingAnorectal Malformations